On 04th February 2025, Dr. Milica Pešić, a representative of the IBISS KTT team in the BIO4 delegation, visited Pfizer's Center for Digital Innovation in Thessaloniki, where she learned how the centre works. During the visit, she gave a short presentation. She presented IBISS as an institution with broad biodiversity, biotechnology, and biomedicine expertise that is open to collaboration and has great innovation potential.
Colleagues from the Department of Biochemistry have been awarded the Hop-on facility project entitled "Widening the investigation of endocrine-disrupting chemicals as contributors to progression of metabolic dysfunction-associated steatotic liver disease" (widenEDC-MASLD) under the HORIZON-WIDERA-2023-ACCESS-06 call.
The Goran Ljubijankić Foundation has presented awards for the best doctoral dissertations and master's theses in the field of molecular biology defended in 2024.
The work of Ana Stepanović and colleagues was selected in the competition of the "Akademik Radoslav K. Anđus" Foundation for the best scientific publication by a young scientist in the field of physiology/biophysics for 2023/2024: Novel hybrid compounds of sclareol and doxorubicin as potential anticancer nanotherapy for glioblastoma, Biomedicine & Pharmacotherapy 174, 2024, 116496.
IBISS uses analytical cookies to analyze the use of the site in order to improve the user experience, by clicking "Accept" you consent to the use of cookies.